Major trial tests if HPV vaccine can block oral cancer risk in HIV-Positive men
NCT ID NCT04255849
Summary
This study is testing whether the 9-valent HPV vaccine can prevent persistent oral HPV infections in men living with HIV. It involves 700 adult men who will receive either the real vaccine or a placebo over several months. Researchers will track whether the vaccine reduces new, lasting oral HPV infections that are linked to throat cancer risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instituto Nacional de Salud Pública, Mexico
Cuernavaca, Morelos, 62209, Mexico
-
Universidade de São Paulo
São Paulo, São Paulo, 05403-911, Brazil
-
University of Puerto Rico AIDS Clinical Trials Unit
San Juan, Purto Rico, 00935, Puerto Rico
Conditions
Explore the condition pages connected to this study.